中晶科技(003026.SZ):法院解除對徐偉的限制消費令
格隆匯5月16日丨中晶科技(003026.SZ)公佈,經求證,2024年5月15日,通州區法院內部執行系統中對鉑鎂醫學臨牀研究(上海)有限公司及徐偉的限制消費措施已解除。公司通過"中國執行信息公開網"和"中國信用網"再次查詢了徐偉的信息,均無相關限制消費措施內容。
公吿顯示,目前,公司經營業務正常開展,未受到該事項的影響。公司將嚴格按照監管要求和有關法律法規的規定履行信息披露義務,維護公司股東合法權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.